These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10779473)

  • 1. Hyperhomocysteinemia, MTHFR, and risk of vascular disease.
    Blom HJ; Verhoef DP
    Circulation; 2000 Apr; 101(16):E171; author reply E173. PubMed ID: 10779473
    [No Abstract]   [Full Text] [Related]  

  • 2. Methylenetetrahydrofolate reductase gene and coronary artery disease.
    Mager A
    Circulation; 2000 Apr; 101(16):E172-3. PubMed ID: 10779474
    [No Abstract]   [Full Text] [Related]  

  • 3. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis.
    Brattström L; Wilcken DE; Ohrvik J; Brudin L
    Circulation; 1998 Dec; 98(23):2520-6. PubMed ID: 9843457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of polymorphic variants of the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene in the pathogenesis of cardiovascular diseases].
    Spiridonova MG; Stepanov VA; Puzyrev VP
    Klin Med (Mosk); 2001; 79(2):10-6. PubMed ID: 11419077
    [No Abstract]   [Full Text] [Related]  

  • 5. Genetic predisposition to hyperhomocysteinemia: deficiency of methylenetetrahydrofolate reductase (MTHFR).
    Rozen R
    Thromb Haemost; 1997 Jul; 78(1):523-6. PubMed ID: 9198208
    [No Abstract]   [Full Text] [Related]  

  • 6. The common mutations C677T and A1298C in the human methylenetetrahydrofolate reductase gene are associated with hyperhomocysteinemia and cardiovascular disease in hemodialysis patients.
    Haviv YS; Shpichinetsky V; Goldschmidt N; Atta IA; Ben-Yehuda A; Friedman G
    Nephron; 2002 Sep; 92(1):120-6. PubMed ID: 12187094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylenetetrahydrofolate reductase gene polymorphism, hyperhomocysteinemia, and cardiovascular diseases in chronic hemodialysis patients.
    Morimoto K; Haneda T; Okamoto K; Ishida H; Kikuchi K
    Nephron; 2002 Jan; 90(1):43-50. PubMed ID: 11744804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced frequency of the thermolabile methylenetetrahydrofolate reductase genotype in the elderly.
    Kluijtmans LA; Whitehead AS
    Atherosclerosis; 1999 Oct; 146(2):395-7. PubMed ID: 10532696
    [No Abstract]   [Full Text] [Related]  

  • 9. Common mutation in the methylenetetrahydrofolate reductase gene offers no support for mild hyperhomocysteinemia being a causal risk factor for cardiovascular disease.
    Brattström L
    Circulation; 1997 Nov; 96(10):3805-7. PubMed ID: 9396508
    [No Abstract]   [Full Text] [Related]  

  • 10. A common methylenetetrahydrofolate reductase gene mutation and longevity.
    Brattström L; Zhang Y; Hurtig M; Refsum H; Ostensson S; Fransson L; Jonés K; Landgren F; Brudin L; Ueland PM
    Atherosclerosis; 1998 Dec; 141(2):315-9. PubMed ID: 9862180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two mutations in the MTHFR gene associated with mild hyperhomocysteinaemia.
    Tikly M; Zannettou N; Traub B
    S Afr Med J; 2003 Mar; 93(3):161-2. PubMed ID: 12768933
    [No Abstract]   [Full Text] [Related]  

  • 12. Hyperhomocysteinemia but not MTHFR genotype is associated with young-onset essential hypertension.
    Garfunkel VA; Porto PI; Garcia SI; Dieuzeide G; Kirszner T; Plotquin Y; Spataro RJ; Gonzalez C; Pirola CJ
    J Hum Hypertens; 2003 May; 17(5):361-4. PubMed ID: 12756410
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hyperhomocysteinemia and C677T mutation of methylenetetrahydrofolate reductase].
    Grasa Ullrich JM; Torres Gómez M; Sánchez Marín B; Calvo Martín MT; García Erce JA; Giralt Raichs M
    An Med Interna; 2002 May; 19(5):269. PubMed ID: 12108010
    [No Abstract]   [Full Text] [Related]  

  • 14. Genetic modulation of homocysteinemia.
    Rozen R
    Semin Thromb Hemost; 2000; 26(3):255-61. PubMed ID: 11011843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperhomocysteinemia: another independent vascular risk factor.
    Deleu D
    Saudi Med J; 2000 Aug; 21(8):787-8. PubMed ID: 11423902
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of vitamin B12 in fasting hyperhomocysteinemia and its interaction with the homozygous C677T mutation of the methylenetetrahydrofolate reductase (MTHFR) gene. A case-control study of patients with early-onset thrombotic events.
    D'Angelo A; Coppola A; Madonna P; Fermo I; Pagano A; Mazzola G; Galli L; Cerbone AM
    Thromb Haemost; 2000 Apr; 83(4):563-70. PubMed ID: 10780318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperhomocysteinemia, MTHFR 677C-->T polymorphism, and stroke.
    Kelly PJ; Barron M; Furie KL
    Stroke; 2002 Jun; 33(6):1452-3; author reply 1452-3. PubMed ID: 12052968
    [No Abstract]   [Full Text] [Related]  

  • 18. C677T substitution in the methylenetetrahydrofolate reductase gene as a risk factor for venous thrombosis and arterial disease in selected patients.
    Gemmati D; Serino ML; Trivellato C; Fiorini S; Scapoli GL
    Haematologica; 1999 Sep; 84(9):824-8. PubMed ID: 10477457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS).
    McQuillan BM; Beilby JP; Nidorf M; Thompson PL; Hung J
    Circulation; 1999 May; 99(18):2383-8. PubMed ID: 10318658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A second common variant in the methylenetetrahydrofolate reductase (MTHFR) gene and its relationship to MTHFR enzyme activity, homocysteine, and cardiovascular disease risk.
    Lievers KJ; Boers GH; Verhoef P; den Heijer M; Kluijtmans LA; van der Put NM; Trijbels FJ; Blom HJ
    J Mol Med (Berl); 2001 Sep; 79(9):522-8. PubMed ID: 11692165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.